Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on transdermal drug delivery system market provides
in-depth analysis of segments and sub-segments in the global as well as
regional transdermal drug delivery system market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
transdermal drug delivery system market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of global transdermal drug delivery system market. According to the
report, the global transdermal drug delivery system market is projected to grow
at a CAGR of 4.3% over the forecast period of 2019-2025.
Transdermal drug delivery system
is a novel drug delivery system designed to deliver a therapeutically effective
amount of drug across a patient’s skin. They are self-contained, the discrete
dosage of drug patches applied to the intact skin, to deliver the drug through
the skin at a controlled rate to the systemic circulation. Transdermal drug delivery
systems enable a steady blood level profile, resulting in reduced systemic side
effects and improved efficacy over other dosage forms such as oral, topical,
intravenous and intramuscular medications.
Globally, the population aged
over 60 is growing faster than all younger age groups. Growing geriatric
population and the rise of several chronic diseases among the elderly
population is driving the growth of the transdermal drug delivery system
market. Transdermal drug delivery system is used for drug delivery among
elderly patients who struggle to swallow their pills or forget to take them
regularly. In addition, the several benefits offered by transdermal drug
delivery system such as enhanced safety, efficacy, and reduced inter and
intrapatient variability increases the adoption of these systems in treating
various chronic illnesses. Furthermore, the transdermal drug delivery system
reduces the risk and inconveniences of parenteral therapy and the increased
demand for minimal invasive therapies favors market growth. However, these
patches are significantly expensive as compared to the conventional treatment
methods and their low adoption in emerging markets restrains the growth of the
transdermal drug delivery system market. Moreover, the increasing application
of transdermal patches to deliver proprietary active pharmaceutical ingredients
(APIs) and generic APIs creates growth opportunities for the transdermal drug
delivery system market.
Geographically, North America
dominates the transdermal drug delivery system market and is anticipated to
remain dominant over the forecast period. The U.S is a key country that is
driving the North America transdermal drug delivery system market. The growth
in this region is mainly attributed to the high prevalence of chronic diseases
and the growing elderly population. Besides this, people in this region have a
high capacity in medical expenditure. Moreover, the presence of several
transdermal drug delivery system manufacturers such as Noven Pharmaceuticals,
Inc, Crescita Therapeutics Inc., Echo Therapeutics, Inc., 3M Drug Delivery
Systems and several others in this region can further increase the revenue
opportunity in this region. Europe is the fastest growing region in the
transdermal drug delivery system market as Europe has 25 percent of the
population aged 60 or over. In Europe, Germany and Italy has the highest number
of the elderly population. The healthcare system in several European countries
are regionally based national health service that provides universal coverage,
with public healthcare free of charge at the point of service, which in turn
provides growth opportunities for Europe transdermal drug delivery system
market.
The report on global transdermal
drug delivery system market covers segments such as product, application, and
facility of use. On the basis of product, the sub-markets include transdermal
patches, and transdermal gels. On the basis of application, the sub-markets
include cardiovascular disease, central nervous system disorders, pain
management, hormonal conditions, and other applications. On the basis of
facility of use, the sub-markets include hospitals and clinics, homecare
settings, and surgical centers.
The report provides profiles of
the companies in the market such as Allergan plc, The 3M Company, Novartis AG,
Biogel Technology, Inc., Echo Therapeutics Inc., Crescita Therapeutics Inc.,
Noven Pharmaceuticals, Inc., Vectura Group plc, Pantec Biosolutions AG, and
Other Companies.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of transdermal drug delivery system market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.